Search Result "Bococizumab"
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors, Reality or Dream in Managing Patients with Cardiovascular Disease
Journal: Current Drug Metabolism
Volume: 20 Issue: 1 Year: 2019 Page: 72-82
Author(s): Mohammad Alkhalil
Pharmacology of PCSK9 Inhibitors: Current Status and Future Perspectives
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3622-3633
Author(s): Aikaterini N. Tsouka,Constantinos C. Tellis,Alexandros D. Tselepis
PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDLCholesterol
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2019 Page: 165-176
Author(s): Yan Wang,Zhao-Peng Liu
PCSK9 Inhibition with Evolocumab Reaching Physiologic LDL-C Levels for Reducing Atherosclerotic Burden and Cardiovascular Disease-The Full Landscape
Ebook: Recent Advances in Alzheimer Research
Volume: 4 Year: 2019
Author(s): Enrique C. Morales-Villegas,Kausik K. Ray
Doi: 10.2174/97816810839951180401
A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 20 Year: 2019 Page: 1790-1817
Author(s): Bo Chen,Xin Shi,Yanping Cui,Aiping Hou,Pengjun Zhao
Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 Monoclonal Antibodies
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 36 Year: 2021 Page: 7427-7445
Author(s): Adel Hajj Ali,Nour Younis,Rola Abdallah,Farah Shaer,Ali Dakroub,Mohammed Akli Ayoub,Rabah Iratni,Hadi Mohamad Yassine,Kazem Zibara,Alexander Orekhov,Ahmed Fawzy El-Yazbi,Ali H. Eid
The Pleiotropic Effects of Statins â From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 3 Year: 2019 Page: 222-232
Author(s): Adam Oesterle,James K. Liao
PCSK9 Inhibition in Atherosclerotic Cardiovascular Disease
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 23 Year: 2023 Page: 1802-1824
Author(s):
PCSK9 Inhibitors and Cardiovascular Disease: Impact on Cardiovascular Outcomes
Journal: Current Drug Discovery Technologies
Volume: 17 Issue: 2 Year: 2020 Page: 138-146
Author(s): Paraskevi Farmaki,Christos Damaskos,Nikolaos Garmpis,Anna Garmpi,Spyridon Savvanis,Evangelos Diamantis
Recent Trials on the Cardioprotective Effects of New Generation Anti-diabetic and Lipid-Lowering Agents
Ebook: Frontiers in Clinical Drug Research-Diabetes and Obesity
Volume: 7 Year: 2023
Author(s):
Doi: 10.2174/9789815123586123070008